Shuqun Cheng
Papers
1
Total Citations
20
H-Index
1
About
Dr. Shuqun Cheng is a leading hepatobiliary surgeon whose research focuses on advancing surgical treatments for hepatocellular carcinoma (HCC), particularly through the comparative evaluation of robotic versus open hepatectomy. His most cited work, a 2023 multicenter study, rigorously examines short-term and long-term outcomes in patients with large HCC, addressing a critical gap in understanding whether the benefits of minimally invasive robotic surgery—such as reduced blood loss and shorter hospital stays—extend to this challenging population. By analyzing data across multiple institutions, Dr. Cheng provides robust evidence that robotic hepatectomy can achieve comparable oncologic outcomes to open surgery while offering perioperative advantages, a finding with significant implications for clinical decision-making. This study has garnered 20 citations, reflecting its timely impact on surgical oncology. Dr. Cheng’s contributions are pivotal in shaping evidence-based guidelines for managing large HCC, and his work continues to influence the adoption of robotic techniques in complex liver resections, ultimately improving patient recovery and survival outcomes.
Research Focus
Key Achievements
Top Papers
- 1